Insider Transactions
| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Aug 20, 2021 |
President & COO
Trans History: 272
|
President & COO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 522,900 | -- | 1,011,499 |
| Aug 20, 2021 |
President & COO
Trans History: 272
|
President & COO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 522,900 | -- | 522,900 |
| Aug 20, 2021 |
Chief Financial Officer
Trans History: 19
|
Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 392,175 | -- | 832,956 |
| Aug 20, 2021 |
Chief Financial Officer
Trans History: 19
|
Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 392,175 | -- | 392,175 |
| Aug 20, 2021 |
VP-General Counsel & Secretary
Trans History: 21
|
VP-General Counsel & Secretary | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 112,500 | -- | 421,451 |
| Aug 20, 2021 |
VP-General Counsel & Secretary
Trans History: 21
|
VP-General Counsel & Secretary | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 112,500 | -- | 112,500 |
| Mar 24, 2022 |
Director
Trans History: 11
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 90,000 | $4.40 | 128,089 |
| Jun 03, 2022 |
Director
Trans History: 11
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 27,353 | -- | 155,442 |
| Jun 03, 2022 |
Director
Trans History: 121
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 27,353 | -- | 245,532 |
| Jun 03, 2022 |
Director
Trans History: 4
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 27,353 | -- | 93,239 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.